Cargando…
Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy
After introduction of levetiracetam (LEV), treatment of seizures in patients with malignant brain tumors has prominently improved. On the other hand, we still experience some cases with LEV-uncontrollable epilepsy. Perampanel (PER) is a noncompetitive α-amino-3-hydroxy-5-methyl-4-isoaxazolepropionat...
Autores principales: | CHONAN, Masashi, SAITO, Ryuta, KANAMORI, Masayuki, OSAWA, Shin-ichiro, WATANABE, Mika, SUZUKI, Hiroyoshi, NAKASATO, Nobukazu, TOMINAGA, Teiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970066/ https://www.ncbi.nlm.nih.gov/pubmed/31748440 http://dx.doi.org/10.2176/nmc.oa.2018-0245 |
Ejemplares similares
-
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid
por: Liguori, Claudio, et al.
Publicado: (2019) -
Non-invasive Evaluation for Epilepsy Surgery
por: IWASAKI, Masaki, et al.
Publicado: (2016) -
Epilepsy in Five Long-term Survivors of Pineal Region Tumors
por: TAKAYAMA, Yutaro, et al.
Publicado: (2021) -
Distribution of postictal slowing has an additional yield to interictal epileptiform discharge in predicting surgical outcomes in temporal lobe epilepsy
por: Shaaban, Sally, et al.
Publicado: (2022) -
DDEL-08. CONVECTION-ENHANCED DELIVERY OF NIMUSTINE HYDROCHLORIDE (ACNU) AGAINST PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMAS
por: Saito, Ryuta, et al.
Publicado: (2020)